Literature DB >> 3956541

Combined treatment modalities of orbital rhabdomyosarcoma in children.

A Fois, A M Bardelli, R Frezzotti, A Acquaviva, C Bernardini, T Hadjistilianou.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3956541     DOI： 10.1007/bf00441754

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  8 in total

1.  Incidence of malignant tumors in U. S. children.

Authors:  J L Young; R W Miller
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

2.  The intergroup rhabdomyosarcoma study: a preliminary report.

Authors:  H M Maurer; T Moon; M Donaldson; C Fernandez; E A Gehan; D Hammond; D M Hays; W Lawrence; W Newton; A Ragab; B Raney; E H Soule; W W Sutow; M Tefft
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

3.  Orbital rhabdomyosarcoma in an infant.

Authors:  G C Sood; D K Sen; R Diwan; A L Aurora
Journal:  Br J Ophthalmol       Date:  1970-03       Impact factor: 4.638

4.  Prognosis in childhood rhabdomyosarcoma.

Authors:  W W Sutow; M P Sullivan; H L Ried; H G Taylor; K M Griffith
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

5.  Prognostic variables in pediatric rhabdomyosarcoma before and after multi-modal therapy.

Authors:  J P Neifeld; H M Maurer; D Godwin; J W Berg; A M Salzberg
Journal:  J Pediatr Surg       Date:  1979-12       Impact factor: 2.545

6.  Orbital rhabdomyosarcoma. An analysis of 62 cases.

Authors:  I S Jones; A B Reese; J Kraut
Journal:  Am J Ophthalmol       Date:  1966-04       Impact factor: 5.258

7.  Multidisciplinary treatment of embryonal rhabdomyosarcoma in children.

Authors:  F Ghavimi; P R Exelby; G J D'Angio; W Cham; P H Lieberman; C Tan; V Miké; M L Murphy
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

8.  Embryonal sarcoma and embryonal rhabdomyosarcoma of the orbit.

Authors:  N Ashton; G Morgan
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.